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A B S T R A C T
Background: Exercise is an effective treatment for osteoarthritis. However, the effect may vary from one
patient (or study) to another.
Objective: To evaluate the efﬁcacy of exercise and its potential determinants for pain, function,
performance, and quality of life (QoL) in knee and hip osteoarthritis (OA).
Methods: We searched 9 electronic databases (AMED, CENTRAL, CINAHL, EMBASE, MEDLINE Ovid, PEDro,
PubMed, SPORTDiscus and Google Scholar) for reports of randomised controlled trials (RCTs) comparing
exercise-only interventions with usual care. The search was performed from inception up to December
2017 with no language restriction. The effect size (ES), with its 95% conﬁdence interval (CI), was
calculated on the basis of between-group standardised mean differences. The primary endpoint was at or
nearest to 8 weeks. Other outcome time points were grouped into intervals, from < 1 month
to  18 months, for time-dependent effects analysis. Potential determinants were explored by subgroup
analyses. Level of signiﬁcance was set at P  0.10.
Results: Data from 77 RCTs (6472 participants) conﬁrmed statistically signiﬁcant exercise beneﬁts for
pain (ES 0.56, 95% CI 0.44–0.68), function (0.50, 0.38–0.63), performance (0.46, 0.35–0.57), and QoL
(0.21, 0.11–0.31) at or nearest to 8 weeks. Across all outcomes, the effects appeared to peak around
2 months and then gradually decreased and became no better than usual care after 9 months. Better pain
relief was reported by trials investigating participants who were younger (mean age < 60 years), had
knee OA, and were not awaiting joint replacement surgery.
Conclusions: Exercise signiﬁcantly reduces pain and improves function, performance and QoL in people
with knee and hip OA as compared with usual care at 8 weeks. The effects are maximal around 2 months
and thereafter slowly diminish, being no better than usual care at 9 to 18 months. Participants with
younger age, knee OA and not awaiting joint replacement may beneﬁt more from exercise therapy. These
potential determinants, identiﬁed by study-level analyses, may have implied ecological bias and need to
be conﬁrmed with individual patient data.
Crown CopyrightC 2019 Published by Elsevier Masson SAS. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).
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Osteoarthritis (OA) of the lower limb is a common joint
condition affecting older people, with approximately 10% to 20% of
people  60 years old worldwide experiencing pain in knees [1]. It
is associated with considerable individual and societal healthcare* Corresponding author.
E-mail address: weiya.zhang@nottingham.ac.uk (W. Zhang).
https://doi.org/10.1016/j.rehab.2019.04.006
1877-0657/Crown CopyrightC 2019 Published by Elsevier Masson SAS. This is an open aburden [2] and accounts for 80% to 90% of hip and knee
replacements in the United States and United Kingdom [3–5].
International guidelines for managing OA recommend exercise as a
core non-pharmacological therapy. Exercise improves symptoms
and the general well-being of people while being relatively safe as
compared with pharmacological treatments [6].
Improved pain and functional outcomes after exercise therapy
in OA are well demonstrated by numerous meta-analyses
[7,8]. However, some gaps in evidence still exist. First, evidenceccess article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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and self-reported function such as quality of life (QoL), muscle
strength, or task performance are still inconclusive [9]. Second,
predictors of treatment response for exercise therapy in OA have
yet to be explored.
This systematic review and meta-analysis aimed to compre-
hensively review the efﬁcacy of exercise therapy for pain, function,
performance, and QoL. In addition, it aimed to preliminarily
explore potential determinants of exercise therapy in knee and hip
OA and to assess whether the effect of exercise is robust to
heterogeneous studies.
2. Methods
This systematic review and meta-analysis is part of a project
with a broader scope, primarily aiming to estimate the relative
efﬁcacy of different types of exercise. The protocol for the wider
project has been registered (PROSPERO CRD42016033865) and
published [10].
2.1. Search strategy
The following electronic bibliographic databases were system-
atically searched from dates of inception to December 2015: Allied
and Complementary Medicine Database (AMED), The Cochrane
Central Register of Controlled Trials (CENTRAL), Cumulative Index
to Nursing and Allied Health Literature (CINAHL), Excerpta Medica
Database (EMBASE), MEDLINE Ovid, Physiotherapy Evidence
Database (PEDro), PubMed, SPORTDiscus, and Google Scholar.
The literature search was updated in December 2017. Reports of
randomised controlled trials (RCTs) in any language were included
as long as trials compared an exercise intervention to a non-
exercise intervention or to another type of exercise in knee and hip
OA. An example of the MEDLINE search is in Appendix 1. Title,
abstract and full text screening was performed by one reviewer
(SLG), validated by a second reviewer (MH). A third reviewer (WZ)
was involved if any discrepancies arose. A similar process was
applied for data extraction with MSMP, JS, YFH and WZ involved in
validations.
2.2. Inclusion criteria
In addition to fulﬁlling the broader search criteria mentioned
above, RCTs also had to fulﬁll the following criteria to be included
in the meta-analysis:
 participants had knee or hip OA and had not undergone knee or
hip joint replacement surgery;
 exercise-only interventions (regardless of exercise type) with-
out additional treatment were examined;
 control groups were assigned to usual care (i.e., controls
receiving no new interventions, including those assigned to
continue their usual physician follow-up, usual physical activity,
or on a ‘‘waiting list’’ for which the active intervention would be
offered only after the study period);
 reporting of pain, function, performance, or QoL outcomes.
2.3. Outcomes
The primary outcome was pain, and secondary outcomes were
self-reported function, objective performance, and QoL. If more
than one scale was reported for an outcome, we selected the scale
that was more comprehensively reported and highest in the
ranking order proposed by Fransen [11] and Regnaux [12].For performance measures, gait/walking parameters (e.g.,
walking distance, walking time etc.) were given priority because
measurement and reporting of these parameters were relatively
standard across trials as compared with other performance
outcomes such as strength/power. Joint-speciﬁc parameters, such
as strength, power, and range of motion, were used only if gait
parameters were not available. Strength parameters were in order
of preference from knee extensors, knee ﬂexors, hip abductors,
and other muscle groups. When tests performed at varying
intensity were reported, the results from the highest intensity
were chosen.
Because of no consensus or evidence to support which of these
physical measures should be the gold standard for assessment in
physical improvements in OA, we believe that any physical
measures used/reported by the authors should be given consid-
eration. Arguably, these measures are clinically different, but in
many instances, a battery of physical tests (i.e., combination of
different parameters and not just one speciﬁc measure) are
recommended for physical assessment of individuals with OA
[13,14].
Furthermore, this meta-analysis adjusted between-measure-
ment differences (by standardizing the difference in means to the
variance of the group measures) before pooling for analysis, just as
different measures of pain with different pain scales were
standardised according to the SD of the measure. This procedure
allowed us to pool the different scales together.
2.4. Study time points
Outcomes reported at different durations of follow-up were
recorded. The primary time point was chosen at or nearest to
8 weeks after baseline/randomisation because this was the most
common point reported. Additionally, the time points were
grouped into intervals (i.e., < 1 month,  1 month,
and  2,  3,  6,  9,  12, and  18 months) to examine time-
dependent effects. For exploring time dependent effects, the
analysis was arbitrarily limited to studies with effect size
(ES) < 2 to minimise bias due to outlying studies. If the number
of studies for a particular time point was small, such outlying data
would contribute to a disproportionately large estimate.
2.5. Handling of multi-arm studies
For studies with > 1 eligible exercise arm and a shared usual
care comparator, only one exercise arm was analysed to avoid
double-counting the participants in the usual care group [15]. Such
studies were handled as follows: 1) if the types of exercise differed,
the exercise that was less frequently investigated by RCTs was
chosen and 2) if the exercises were similar, the exercise
intervention groups were aggregated for analysis. For example,
if an RCT had 4 groups — group 1 (supervised Tai-chi), group 2
(unsupervised Tai-chi), group 3 (strengthening exercise), and
group 4 (usual care) — the Tai-chi exercise groups would be
selected for analysis above the strengthening group because Tai-
chi trials are comparatively scarce in the literature. Because groups
1 and 2 are similar exercise types, data from these 2 groups would
be aggregated before being compared to usual care. In some cases,
one study may provide 2 sets of ESs such as when outcomes for
knee and hip OA or for males and females were reported
separately. Details of the calculations and method of aggregation
are in the published protocol [10].
2.6. Calculation of ES and SD
The mean change score (mean end-point minus mean baseline
score) was calculated for each group. The SD of the change
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2 + SD1
2 - 2  r  SD0  SD1) [16],
where r is the correlation coefﬁcient between baseline
and endpoint outcome scores. We assumed r to be 0.5 in this
analysis. The ES was calculated by using the between-group
standardised mean difference (SMD) following Cohen’s method
[16]. With this deﬁnition, an ES 0.2, 0.5, and 0.8 is considered
small, moderate or large, respectively [17]. We attempted to
contact authors for missing data but were rarely successful. If the
change score could not be extracted or derived, the mean
endpoint score was used instead. If a report did not give the
within-group SD or did not provide sufﬁcient information to
calculate it, the missing SD was imputed from other studies. The
missing SD was imputed by using the largest SD of the same scale
reported for other trials if available; otherwise an arithmetic
mean of other SDs was used [18]. A random effects model was
used to pool the data. Data analysis involved using Stata
(StataCorp. 2017. Stata Statistical Software: Release 15. College
Station, TX).
2.7. Determinants
Subgroup analyses were performed to identify potential
determinants of efﬁcacy according to the following study
characteristics that were commonly reported in exercise trials:
 Clinical characteristics:
 mean age – < 60 or  60 years (dichotomised according to the
international guideline of aging population [19]),
 mean body mass index (BMI) – < 30 or  30 kg/m2, which
corresponds to a classiﬁcation of obesity [20],
 percentage of female participants arbitrarily divided into < 60%,
60% to 80% or  80%,
 joint sites (knee OA, hip OA, or mixed knee and hip OA),
 whether or not participants were recruited from waiting lists for
joint surgery.
 Methodological characteristics:
 pain criteria (whether a pain severity threshold was set as
inclusion criteria),
 American College of Rheumatology (ACR) criteria (whether
recruitment was based on ACR criteria),
 radiographic criteria (whether radiographic changes were
required for recruitment),
 recruitment setting (specialist/hospital cohort, general practi-
tioner [GP]/community, mixed cohort). Studies with unclear
recruitment were excluded from subgroup analysis,
 whether adherence was monitored,
 whether monitoring or control for pharmacological analgesics
was reported,
 whether intention-to-treat (ITT) analysis was undertaken,
 whether the study had > 100 participants per arm,
 whether walking parameters or other physical test parameters
were used to measure performance,
 whether a disease-speciﬁc or generic tool was used to assess QoL
changes.
These variables were selected for their potential as effect
modiﬁers of exercise response (e.g., joint site, mean age) or as
sources of bias (e.g., adherence, ITT analysis, sample size).
2.8. Meta-regression
Any potential covariates of the effect of exercise with
P  0.10 identiﬁed on univariate meta-regression were subse-
quently included in multivariate meta-regression modelling. The
level of signiﬁcance for multivariate meta-regression was also set
at P  0.10 [21].2.9. Sensitivity analysis
Analyses were repeated in the following ways to assess whether
the results were robust:
1. using scores at end points instead of change scores;
2. including outliers;
3. excluding studies that had imputed SD;
4. excluding studies that assessed 2, rather than 1, index knee in
each participant;
5. excluding translated publications; and
6. excluding studies with high heterogeneity as assessed by Baujat
plots [22].
The Baujat plot is useful for visually assessing the source of
heterogeneity because studies with high contributions to hetero-
geneity and the overall pooled estimate can be identiﬁed. These
studies were excluded sequentially until the I2 statistic (an
indicator of unexplained heterogeneity) was < 30%. A level of
30% suggests unremarkable inﬂuence of subgroup diversity, 30% to
60% suggests moderate heterogeneity, 50% to 90% substantial
heterogeneity, and 75% to 100% considerable heterogeneity
[16,23].
2.10. Risk of bias assessment
A modiﬁed Cochrane risk of bias assessment tool was used to
assess the quality of studies [24]. Various sources of bias were
assessed by examining the methods of randomisation, conceal-
ment, blinding, and handling of missing data. Responses for each
criterion were scored as yes, no, or unclear. Because the risk of bias
can differ across outcomes [25], the scoring was based on pain
outcomes whenever possible. For assessor blinding, the scoring
was based on studies with performance outcomes and not on
outcomes that were self-reported (pain, function and QoL).
Funnel plots were used to assess for small study effect/
publication bias.
3. Results
3.1. Characteristics
From the citations retrieved by December 2017, a total of 239
(217 RCTs) met the broad inclusion criteria. However, only 77 RCTs
(6472 participants) fulﬁlled the speciﬁc eligibility criteria for the
present meta-analysis (see Fig. 1).
The outcome most frequently reported in the trials was
objective performance (72 trials; 5913 participants), followed by
pain (69 trials; 6072 participants), function (64 trials; 5829 parti-
cipants), and QoL (34 trials; 3058 participants) (Table 1). The age
and sex distributions were similar across all outcomes. Knee OA
was the most commonly studied joint site. More than half of the
time points reported were < 3 months after start of the interven-
tion, with 8 weeks being the most commonly reported time point.
Therefore, we used outcomes at or nearest to 8 weeks after
baseline assessment/randomisation as our endpoint for this meta-
analysis. The characteristics and risk of bias assessment for each
trial are in Appendices 2A and 2B, respecetively.
On preliminary examination of funnel plots, pain and QoL had
one outlier each (ES > 5). These studies were excluded from the
analyses and are not represented in the funnel plots shown in
Appendix 3. Egger’s test for publication bias was signiﬁcant
(P < 0.05) for all outcomes except QoL.
Because exercise interventions cannot be blinded, the greatest
risks of bias were for items related to the blinding of physicians and
patients. For 52% of the trials with performance outcomes, blinding
Fig. 1. Flow diagram of study selection. RCT, randomised controlled trial.
Table 1
Study characteristics of included studies (n = 77 trials, 6472 participants).
Reported outcomes
Pain Function Performance QoL
No. of comparisons (no. of RCTs) 70 (69) 65 (64) 73 (72) 34 (34)
No. of participants 6072 5829 5913 3058
% females per trial (range) 73.2 (40.4–100.0) 73.2 (40.4–100.0) 73.3 (40.4–100.0) 72.6 (40.4–100.0)
Age, years, median (range) 64.8 (41.3–84.4) 65 (41.3–84.4) 64.8 (41.3–77.0) 64.9 (49.4–84.4)
BMI, kg/m2, median (range) 29.8 (23.8–38.1) 29.8 (23.8–38.1) 29.6 (23.8–38.1) 29.9 (23.8–37.3)
Joint studied (no. of RCTs [%])
Knee 55 (80) 50 (78) 56 (78) 24 (71)
Hip 8 (12) 9 (14) 9 (13) 7 (21)
Both 6 (9) 5 (8) 7 (10) 3 (9)
OA deﬁnition*
ACR 32 31 35 13
Radiographic 38 37 39 19
Trial data points, months
1 17 16 16 13
2 26 26 30 9
3 21 17 21 7
6 3 3 1 3
 12 3 3 5 2
QoL: quality of life; BMI: body mass index; ACR: American College of Rheumatology.
* Radiographic diagnosis was mandatory in some studies and some studies merely indicated that ACR criteria was fulﬁlled.
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Fig. 2. Forest plot of exercise versus usual care for pain.
S.-L. Goh et al. / Annals of Physical and Rehabilitation Medicine 62 (2019) 356–365360of assessors was adequate. Assessor blinding was not scored for
RCTs that reported only self-reported outcomes (see Appendix 4).
Other items with >50% low risk of bias were related to adequate
randomisation (62%), missing outcomes reporting (53%), use of ITT
(61%), homogeneity of baseline characteristics (77%), and reporting
as pre-speciﬁed (95%).
3.2. Effect sizes
Relative to usual care at or nearest to 8 weeks, exercise
conferred a moderate beneﬁt for pain relief (ES 0.56, 95% CI
0.44–0.68) (Fig. 2), function (0.50, 0.38–0.63), and performance
(0.46, 0.35–0.57). A smaller but still statistically signiﬁcant beneﬁt
was observed for QoL (0.21, 0.11–0.31) (Appendix 5).
We found a general trend for the effects of exercise therapy to
peak at 2 months for all outcomes, especially when considering
that a reasonable number of trials contributed to the data at each
time point (i.e., started from month 1 [Fig. 3]). The effects werereduced gradually after 2 months and became no better than the
usual care group at 9 to 18 months depending on the outcome.
3.3. Potential determinants
According to the predeﬁned threshold of P  0.10 with the
univariate meta-regression in subgroup analysis, we found
signiﬁcantly better pain relief for trials with participants who
were younger (< 60 years), with more women, with knee OA and
participants not on a waiting list for joint replacement and trials
with no/unclear ITT analysis (Table 2). However, after adjustment
for covariates on multivariate meta-regression, only younger age,
knee OA and not on a waiting list for joint replacement were
signiﬁcant (Table 2).
For function, response to exercise therapy was better for trials
of participants with younger age (mean age < 60 years), knee OA,
and without adherence monitoring according to the predeﬁned
threshold of P  0.10 in subgroup analysis (Appendix 6A).
Fig. 3. The summary effect of exercise for all outcomes at various times.
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signiﬁcant after adjusting for covariates on multivariate meta-
regression. A similar process was repeated for performance and
QoL outcomes. Apart from trials recruiting from a speciﬁc setting/
hospital for performance, no other determinants were signiﬁcant
(Appendices 6B and 6C).
3.4. Sensitivity analyses
Sensitivity analyses indicated that the effect of exercise across
all outcomes was relatively robust. The 95% CIs were overlapping
regardless of whether ﬁnal scores were used instead of change
scores, the included studies had imputed SDs, the studies
exclusively analysed one index knee per person, or translated
publications were included (Appendix 7).
Additional sensitivity analyses were performed by examining
only ‘‘homogeneous’’ RCTs. The 95% CIs for the new pooled ES
values obtained with ‘‘homogeneous’’ RCTs still overlapped withthose obtained from the primary analysis. With the I2 now < 30%,
the new ES estimate for pain was 0.50 (95% CI 0.43–0.58), function
0.43 (0.35–0.51), performance 0.32 (0.25–0.39), and QoL 0.18
(0.09–0.27) (Fig. 4). No single factor could be identiﬁed to account
for the heterogeneity of the outlying RCTs.
4. Discussion
This meta-analysis conﬁrmed the ﬁndings of previous reports
[26–28] that exercise is superior to usual care for OA at 8 weeks.
The beneﬁts of exercise were greater for pain, function, and
performance than for QoL. The efﬁcacy of exercise over usual care
was generally the greatest at 2 months after starting exercise and
were gradually reduced over time to become no better than usual
care at 9 to 18 months depending on outcomes. Trials in which the
participants were younger, on average; had knee OA; and were not
awaiting joint replacement reported better pain relief after
exercise therapy. Similarly, trials with younger participants also
Table 2
Subgroup analysis and potential determinants for pain.
No. comp. (No. trials) No. patients Effect Size (95%CI) I2 (%) P-value
Univariate Multivariate
Overall 69 (68) 5272 0.56 (0.44, 0.68) 74.1
Age, years
< 60 12 591 1.32 (0.79–1.86) 86.9 < 0.01* 0.04*
 60 57 4681 0.44 (0.34–0.55) 62.6
% Femalea
<60% 14 1156 0.27 (0.10–0.44) 46.2 0.09* 0.31
 60% 30 2731 0.60 (0.41–0.78) 79.0
 80% 22 1291 0.56 (0.39–0.74) 50.2
Mean BMI, kg/m2a
< 30 26 2052 0.46 (0.38–0.60) 53.3 0.78 –
 30 18 1187 0.56 (0.28–0.84) 79.8
Joint
Knee 55 3750 0.64 (0.51–0.78) 71.2 0.02* 0.10*
Hip 8 703 0.17 (-0.17–0.51) 76.8
Mixed 6 819 0.43 (0.13–0.72) 73.6
On TJR waiting list
No 55 4481 0.62 (0.49–0.75) 74.0 0.10* 0.10*
Yes 14 791 0.33 (0.04–0.63) 73.5
‘‘Explicit’’ pain criteria
None 56 3965 0.59 (0.44–0.73) 76.2 0.64 –
Yes 13 1307 0.49 (0.30–0.68) 62.0
ACR criteria
Yes 33 2585 0.64 (0.45–0.82) 78.8 0.39 –
No/unclear 36 2687 0.46 (0.32–0.60) 66.7
Radiographic requirement
Yes 39 2649 0.66 (0.46–0.85) 80.9 0.27 –
No/unclear 30 2623 0.46 (0.33–0.59) 53.4
Adherence monitored
Yes 45 3961 0.49 (0.36–0.63) 73.2 0.17 –
No/unclear 24 1311 0.73 (0.48–1.00) 74.7
Analgesic controlled/monitored
Yes 33 2821 0.55 (0.38–0.73) 77.8 0.86 –
No/unclear 36 2451 0.58 (0.41–0.74) 70.1
Recruitment centrea
Specialist/hospital 27 1867 0.50 (0.31–0.69) 72.4 0.91 –
GP/community 26 2405 0.50 (0.32–0.67) 72.7
Mixed 7 680 0.46 (0.30–0.60) 7.1
ITT use
Yes 44 3574 0.47 (0.33–0.60) 73.7 0.06* 0.54
No/unclear 25 1698 0.76 (0.55–1.00) 72.7
> 100/group
Yes 5 1356 0.31 (0.05–0.58) 82.9 0.25 –
No 64 3916 0.60 (0.46–0.73) 72.5
95% CI: 95% conﬁdence interval; No. comp.: number of comparators; BMI: body mass index; ACR: American College of Rheumatology; GP: general practitioner; ITT: intent-to-
treat; OA: osteoarthritis; TJR: total joint replacement.
* Signiﬁcant at P  0.10.
a Data were missing in some studies.
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therapy.
The pattern of the time-dependent effect was similar for all
outcomes (i.e., increased in the ﬁrst 2 months, then gradually
reduced thereafter). The greater effect observed within 1 month
may be due to the small study effect [29] because only 1 or 2 trials
were involved in this estimate. The gradual diminishing efﬁcacy
observed after the peak at 2 months agrees with the meta-analysis
by Fransen et al. [11]. The authors also examined the longer-term
effects of exercise in knee OA and found that the effects on pain and
function were reduced by at least half between month 2 and 6 as
compared with effects achieved within the ﬁrst 2 months. One of
the reasons for this decline may be poor exercise adherence, in
which personal beliefs, social support, relationship with provider
and ease of access to exercise facilities play important roles [30].
Overall, the results support the inverse association between
exercise beneﬁts and OA severity (i.e., exercise is believed to
produce greater improvement with milder than more severe OA)
[31]. Patients on waiting lists for surgery, who generally represent
OA at the more advanced stage of the clinical spectrum, showed asmaller exercise response as compared with those not on a waiting
list. Although we observed smaller exercise beneﬁts in trials with
older patients, to what extend this ﬁnding is related to OA severity
alone is uncertain. In the older population, other age-related
conditions (e.g., impaired cellular function, reduced functional
reserve in cardiovascular and musculoskeletal systems, and
additional health burden of co-morbidities) [32–34] could also
account for the lower effect observed.
For all outcomes, improvement was generally better for
participants who were recruited from specialist/hospital centres
versus GP/community or mixed recruitment settings. However,
recruitment setting was a signiﬁcant predictor for only perfor-
mance. Considering that participants recruited from specialist/
hospital settings may coincidentally have increased prevalence of
severe OA, this ﬁnding did not concur with the other analyses
supporting greater exercise beneﬁts with milder OA. Instead this
result may support the moderating role of exercise facilitators or
the context of exercise delivery because such centres would
generally be better equipped and perhaps better supported to
encourage exercise adherence. However, considering that we
Fig. 4. Effect size (ES) for all outcomes by including only ‘‘homogeneous’’ studies (blue shaded area). Blue text: results obtained when sources of heterogeneity (studies in
unshaded area) were removed to achieve I2 < 30%. Overall results refer to original estimate obtained with all studies. Data in parenthesis represent 95% conﬁdence interval, I2:
I2 statistic, n: number of studies.
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specialist/hospital subgroup, some caution is warranted in the
interpretation.
Similarly, the observation that functional improvement was
signiﬁcantly better in studies without explicit exercise adherence
monitoring needs to be interpreted with caution. On one hand, the
differentiation may be related to the ease or feasibility of reporting
and monitoring of attendance. For example, it may be easier and
more reliable to report adherence based on an objective measure of
class attendance than self-reported exercise diaries [35]. Also,
studies with longer follow-up may be more likely to monitor
exercise adherence than studies of short duration. On the other
hand, the overall analysis suggests that RCTs with less rigorous
methods (small sample size, unclear/no exercise adherence
monitoring, no explicit use of ITT) or RCTs that were heterogeneous
tended to inﬂate the effect of exercise.
The effect of exercise on QoL was smaller than that for other
outcomes and was not inﬂuenced by the type of instrument used
(generic or disease speciﬁc). One plausible explanation is the
difﬁculty in using a standardised instrument to measure a
construct that is individually unique, considering that preferences
and expectations vary among individuals [36]. Furthermore, QoL is
multidimensional and standardized tools cannot adequately
accommodate all factors considered important for all individuals.
Unlike previous meta-analyses, this analysis included a large
number of studies, examined more outcomes, and included alltypes of exercise. To examine effect-modiﬁers (i.e., determinants),
the study focused on exercise programs that were administered
alone without additional concurrent treatment. In addition, we
limited the control group to usual care and excluded other active
non-exercise controls (e.g., patient education or manual therapy)
to ensure that the reference arm was standardised. This approach
allowed us to explore the effect of potential effect-modiﬁers (e.g.,
joint affected, type of exercise, heterogeneous RCTs) by subgroup
analysis.
A major limitation of the study is the observational nature of
meta-analysis. The results were heavily reliant on the accuracy and
comprehensiveness of the primary report. Some issues encoun-
tered were missing data on important covariates (such as mean
age, sex distribution), and incomplete reporting of group
outcomes. Studies with missing data were not included in
regression analysis. As a result, the power to perform adjustment
for multiple comparisons was limited. Another limitation associ-
ated with study-level analyses is ecological bias as well as other
problems associated with heterogeneity between studies. Ecologi-
cal bias occurs because the average change observed at the group
level does not accurately reﬂect the change that occurs within each
individual member of the group. Heterogeneity between studies
occurs because of variations in patients, disease and methodologi-
cal characteristics [37]. Particularly for exercise trials, the problem
with heterogeneity extends into the interventions used and choice
of controls. Despite being widely accepted as a reasonable
S.-L. Goh et al. / Annals of Physical and Rehabilitation Medicine 62 (2019) 356–365364surrogate for placebo in exercise trials, we have no uniﬁed
deﬁnition of what ‘‘usual care’’ should comprise. With the above
limitations, the aim of this analysis was to generate hypotheses to
guide future individual patient-data meta-analyses. We had also
set a slightly higher statistical signiﬁcance level (P  0.10) to
ensure that we would not miss any potential determinants at this
stage [38].
The other limitation is related to the poor quality of clinical
trials in exercise. In addition to inadequate blinding of participants
and investigators due to the nature of the intervention, a great
proportion of exercise RCTs demonstrated high risks of bias in
other domains such as reporting bias, allocation concealment and
small sample size. The presence of a small study effect in some of
the outcomes further downgrades the quality of the evidence.
Although a quality assessment tool speciﬁcally designed for
exercise trials has recently become available [39], no composite
scoring system has been developed to grade whether a particular
exercise trial is of good or bad quality. Therefore, we could not
calculate a single point estimate for exercise effect based on only
good-quality studies. Instead, a subset of selected indicators of
study quality that we felt were most relevant for exercise trials
were used to assess the robustness of our results with subgroup
and sensitivity analyses [40].
In conclusion, this meta-analysis compared the efﬁcacy of all
types of exercise versus usual care for 4 important knee and hip OA
outcomes: pain, function, performance, and QoL. The results
showed that, at 8 weeks, exercise had signiﬁcant moderate beneﬁts
for pain and function. Beneﬁts for QoL were small but still
signiﬁcant. The effects often built up to 2 months, then gradually
decreased by 9 to 18 months depending on the outcome. Outcomes
were better for trials of participants with mean age < 60 years,
with knee OA, and not on a waiting list for joint replacement, in a
hospital setting, and with no explicit report of adherence
monitoring. Further work in individual patient data is still needed
to conﬁrm these ﬁndings.
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